<DOC>
	<DOCNO>NCT01138826</DOCNO>
	<brief_summary>This study perform determine bioavailability , extent absorption body , 10 mg amlodipine besylate orally disintegrate tablet ( ODT ) compare bioavailability 10 mg amlodipine besylate ( non-ODT ) tablet .</brief_summary>
	<brief_title>Bioavailability Study Comparing 10 Mg Amlodipine Besylate Orally Disintegrating Tablet ( ODT ) And 10 Mg Amlodipine Besylate Tablets</brief_title>
	<detailed_description />
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Healthy male and/or female subject ( Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12lead ECG clinical laboratory test ) . Body Mass Index ( BMI ) 18 26 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . A positive urine drug screen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>biological availability</keyword>
	<keyword>bioavailability</keyword>
	<keyword>amlodipine</keyword>
	<keyword>orally disintegrate tablet</keyword>
	<keyword>ODT</keyword>
	<keyword>tablet</keyword>
</DOC>